Rescue Therapy Use in Patients with Diabetic Macular Edema (DME) Receiving Intravitreal Aflibercept (IVT-AFL) or Laser: Results from the VIVID-DME and VISTA-DME Trials

被引：0

作者：

Rehak, Matus ^{[1
]}

Korobelnik, Jean-Francois ^{[2
]}

Metzig, Carola ^{[3
]}

机构：

[1] Charite, D-13353 Berlin, Germany

[2] Hop Pellegrin, F-33076 Bordeaux, France

[3] Bayer Healthcare, Berlin, Germany

来源：

OPHTHALMOLOGICA | 2014年 / 232卷

关键词：

Diabetic Macular Edema; Rescue Therapy; Diabetic Retinopathy; Anti-Vascular Endothelial Growth Factor; Aflibercept;

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

147

引用

页码：17 / 18

页数：2

共 46 条

[1] Rapid Response to Intravitreal Aflibercept (IVT-AFL) in Patients with Diabetic Macular Edema (DME) in the Vivid-dme and Vista-DME Trials
Varano, Monica
Korobelnik, Jean-Francois
Parravano, Mariacristina
Katz, Todd A.
Metzig, Carola
OPHTHALMOLOGICA, 2014, 232 : 22 - 22
[2] Intravitreal Aflibercept (IVT-AFL) for Diabetic Macular Edema (DME): 3 Year Data from VIVID-DME and VISTA-DME
Staurenghi, G.
Metzig, C.
ACTA OPHTHALMOLOGICA, 2015, 93
[3] Impact of Intravitreal Aflibercept (IVT-AFL) on Diabetic Retinopathy in the VIVID-DME and VISTA-DME Studies
Larsen, L. M.
Metzig, C.
ACTA OPHTHALMOLOGICA, 2015, 93
[4] TIME COURSE OF VISUAL ACUITY CHANGES WITH INTRAVITREAL AFLIBERCEPT (IVT-AFL) OR MACULAR LASER PHOTOCOAGULATION IN PATIENTS WITH DIABETIC MACULAR EDEMA (DME): OUTCOMES FROM THE VIVID-DME AND VISTA-DME CLINICAL TRIALS
McAllister, Ian
Holz, Frank
Metzig, Carola
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 42 : 13 - 13
[5] INTRAVITREAL AFLIBERCEPT FOR THE TREATMENT OF DIABETIC MACULAR EDEMA (DME): FINDINGS FROM THE VIVID-DME AND VISTA-DME CLINICAL TRIALS
Midena, E.
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2014, 24 (03) : 459 - 459
[6] Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: A review of VIVID-DME and VISTA-DME data
Ziemssen F.
Schlottman P.G.
Lim J.I.
Agostini H.
Lang G.E.
Bandello F.
International Journal of Retina and Vitreous, 2 (1)
[7] Evaluation of Intravitreal Aflibercept for Treatment of Diabetic Macular Edema: Visual Acuity Subgroups in VIVID-DME and VISTA-DME
Lorenz, Katrin
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[8] Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies
Mitchell, Paul
McAllister, Ian
Larsen, Michael
Staurenghi, Giovanni
Korobelnik, Jean-Francois
Boyer, David S.
Do, Diana, V
Brown, David M.
Katz, Todd A.
Berliner, Alyson
Vitti, Robert
Zeitz, Oliver
Metzig, Carola
Lu, Chengxing
Holz, Frank G.
OPHTHALMOLOGY RETINA, 2018, 2 (10): : 988 - 996
[9] Impact of Prior Therapy for Diabetic Macular Edema (DME) on Visual and Anatomic Outcomes Following Treatment with Intravitreal Aflibercept: Results from the Phase 3 VISTA-DME and VIVID-DME Studies
Quan Dong Nguyen
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
[10] Intravitreal Aflibercept Injection (IAI) for Diabetic Macular Edema (DME): Primary and Additional Endpoint Results from the 12-Month Phase 3 VISTA-DME and VIVID-DME Studies
Brown, David M.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)

← 1 2 3 4 5 →